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Chlorhexidine. After repeated exposure to chlorhexidine both S. aureus and E. coli 201 showed ≥4 fold increases in MIC and MBC which partially reverted in the absence of the 202 microbicide (Table 3) . P. aeruginosa demonstrated a ≥4 fold increase in MIC which did not 203 revert after regrowth in a chlorhexidine free environment. E. faecalis and M. osloensis exhibited 204 ≥4 fold increases in MBEC, which partially and fully reverted in the absence of chlorhexidine 205 respectively. In contrast, after exposure to chlorhexidine formulation no bacterium exhibited a 206 ≥4 fold decrease in susceptibility at MIC, MBC or MBEC level.
Didecyldimethyl Ammonium Chloride. After repeated DDAC exposure P. aeruginosa, 208 A. baumanii and the E .coli drain isolate exhibited a ≥4 fold increase in MBC, of which P. 209 aeruginosa fully reverted whilst A. baumanii and E. coli partially reverted following repeated 210 growth the absence of DDAC. S. aureus. E. coli, E. faecalis and the E. coli drain isolate all 211 exhibited a ≥4 fold increase in MBEC, out of which E. faecalis and the E. coli drain isolate 212 partially reverted, E. coli fully reverted and S. aureus did not revert back to pre-exposure values 213 following growth in the absence of the microbicide ( coli drain isolate showed partial reversion and E. coli and P. aeruginosa showed no reversion to 10 pre-exposure values in the absence of PHMB. After PHMB exposure, S. aureus, E. faecalis, A. 233 baumanii, C. sakazakii, and the E. coli drain isolate also displayed a ≥4 fold increase in MBEC, 234 which fully reverted for S. aureus, A. baumanii and E. coli drain isolate, and partially reverted 235 for E. faecalis and C. sakazakii after re-growth in the absence of PHMB. After exposure to 236 PHMB formulation S. aureus, E. faecalis and P. aeruginosa showed substantial changes in their 237 PHMB susceptibility displaying ≥4 fold increases in MBC all of which fully or partially 238 reverted in the absence of the antimicrobial formulation. S. aureus and E. faecalis also exhibited 239 a ≥4 fold increase in MBEC after exposure to PHMB formulation, all of which partially reverted 240 back to pre-exposure values after regrowth in the absence of the formulation.
241
Thymol. After long-term thymol exposure none of the bacterial isolates showed a ≥4 242 fold decrease in thymol susceptibility at MIC, MBC or MBEC level (Table 7) . After exposure to 243 the thymol-containing formulation, E. coli and A. baumanii both underwent ≥4 fold increases in 244 MBC whilst P. putida demonstrated a ≥4 fold increase in MIC and MBC, all of which partially 245 reverted in the absence of thymol formulation. Furthermore, both E. coli isolates showed a ≥4 246 fold increase in MBEC, which partially reverted after growth in the absence of thymol 247 formulation.
248
Triclosan. All bacterial isolates, with the exception of E. faecalis, A. baumanii and P. 249 aeruginosa, which is non-susceptible to triclosan, demonstrated an increase in MIC after 250 repeated triclosan exposure, none of which fully reverted back to pre-exposure levels after hydantoin, thymol and PHMB containing formulations induced the largest number of ≥4-fold 332 increases in MBC (3 isolates each) followed by BAC and DDAC (2 isolates each). Exposure to 333 the DDAC containing formulations resulted in the highest numbers of bacterial isolates 334 exhibiting a ≥4-fold increase in MBEC (4 isolates), followed by BAC and DMDM hydantoin (3 335 isolates) then PHMB, thymol and triclosan formulations (2 isolates).
337
Whilst the current investigation demonstrates that induced reductions in susceptibility towards 338 both microbicides and microbicide-containing formulations may occur, a substantially higher 339 number of bacterial isolates underwent ≥4-fold increases in MIC, MBC or MBEC when exposed 340 to microbicides in aqueous solution, in comparison to those in formulation. The only exception 341 to this was thymol, for which changes in susceptibility were more frequent in bacteria exposed 342 to the compound in formulation. Thymol is poorly soluble in water and formulation may 343 therefore have substantially improved solubility, increasing bacterial exposure and thus Table 1 . Bacterial susceptibility towards benzalkonium chloride in planktonic and biofilm growth modes before, during and after repeated exposure to 539 benzalkonium chloride in aqueous solution or in formulation 540 MIC, minimum inhibitory concentration; MBC, minimum bactericidal concentration; MBEC, minimum biofilm eradication concentration.
541
Before antimicrobial exposure (P0); during antimicrobial exposure (P14) and after passage in the absence of antimicrobial (X14) All values are in mg/L. †, 542 non-drain isolates; *, drain isolates. UF, unformulated (microbicide in aqueous solution); F, formulated (microbicide in formulation). Organisms that 543 underwent a ≥4-fold increase in MIC, MBC or MBEC (as indicated by bold text) were passaged a further 14 times in the absence of microbicide. na, bacteria 544 that did not undergo a ≥4-fold change and were not assessed for reversibility. Data represents six replicates. Where data varied between biological replicates, 545 standard deviations have been given in parentheses. In controls were bacteria were tested against formulations without microbicide, all bacteria were non-546 susceptible to in-use concentrations. 
